September 28, 2020
An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.
September 25, 2020
A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.
September 23, 2020
Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.
September 23, 2020
Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.
September 22, 2020
A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.
September 22, 2020
A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.
June 16, 2020
New data released today from the Diabetes Prevention Program Outcomes Study (DPPOS) shows that in over 2000 patients followed for an average of 22 years, lifestyle programs and treatment with metformin continues to prevent the development of type 2 diabetes in at risk populations.
June 15, 2020
New data from the Environmental Determinants of Diabetes in the Young (TEDDY) study illuminate the environmental triggers that are thought to cause the autoimmune response leading to type 1 diabetes(T1D) and celiac disease. The data was presented in a symposium at the American Diabetes Association meeting.
April 06, 2017
Could corticosteroid use put your patients at a greater risk of metabolic syndrome?
April 04, 2017
Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.